Your browser version may not work well with NCBI's Web applications. More information
here...
-
- Erratum in:
- N Engl J Med 1990 Jan 25;322(4):280.
Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and related dideoxynucleosides.
Clinical Oncology Program, National Cancer Institute, Bethesda, MD 20892.
PMID: 2671731 [PubMed - indexed for MEDLINE]
-
Related Articles
-
The antiretroviral and cytostatic activity, and metabolism of 3'-azido-2',3'-dideoxythymidine, 3'-fluoro-2',3'-dideoxythymidine and 2',3'-dideoxycytidine are highly cell type-dependent.
[Adv Exp Med Biol. 1989]
-
Clinical applications of 3'-azido-2',3'-dideoxythymidine (AZT) and related dideoxynucleosides.
[Med Res Rev. 1990]
-
Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.
[J Exp Med. 1988]
-
5-Chloro-substituted derivatives of 2', 3'-didehydro-2',3'-dideoxyuridine, 3'-fluoro-2',3'-dideoxyuridine and 3'-azido-2',3'-dideoxyuridine as anti-HIV agents.
[Biochem Pharmacol. 1989]
-
In vitro bone marrow toxicity of nucleoside analogs against human immunodeficiency virus.
[Antimicrob Agents Chemother. 1989]
-
ยป See all Related Articles...